Financial statements Direct Pharma Polska

Balance sheet of Direct Pharma Polska

Company age:
Age:
7 y. 11 m. 3 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of DIRECT PHARMA POLSKA

Year
2018
2019
2020
2021
2022
2023
Total assets 431 447,13 935 472,79 1 554 030,89 2 137 806,25 1 695 676,59 1 687 654,53
A. Fixed assets 102 286,28 105 167,45 99 918,02 76 774,78 67 885,90 67 885,90
B. Current assets 329 160,85 830 305,34 1 454 112,87 2 061 031,47 1 627 790,69 1 619 768,63
C. Share capital contributions (basic funds) - - - - - -
D. Own shares (stocks) - - - - - -
Total liabilities 431 447,13 935 472,79 1 554 030,89 2 137 806,25 1 695 676,59 1 687 654,53
A. Equity 339 228,57 204 058,43 -11 986,04 21 616,20 -61 045,78 -200 203,85
B. Liabilities and provisions for liabilities 92 218,56 731 414,36 1 566 016,93 2 116 190,05 1 756 722,37 1 887 858,38
I. Long-term liabilities 0,00 0,00 20 000,00 - - -
II. Short-term liabilities 92 218,56 731 414,36 1 546 016,93 - - -
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.